HighRAD Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

HighRAD General Information

Description

Developer of an AI imaging platform designed to advance oncology care by tracking disease progression across the full patient journey through longitudinal, multi-organ analysis. The company's platform offers quantitative imaging analysis, automated lesion measurement, workflow integration, and standardized reporting, enabling radiologists, oncologists, and pharmaceutical research teams to gain deeper disease insight, make more confident clinical decisions, and improve treatment planning.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 132 Menachem Begin Street, Azrieli Center
  • Round Tower Floor 22, PO Box 67
  • Tel Aviv 6702101
  • Israel
+972
Primary Industry
Outcome Management (Healthcare)
Other Industries
Decision/Risk Analysis
Corporate Office
  • 132 Menachem Begin Street, Azrieli Center
  • Round Tower Floor 22, PO Box 67
  • Tel Aviv 6702101
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HighRAD Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Nov-2024 Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC 01-Jul-2022 Completed Generating Revenue
1. Early Stage VC 01-Jan-2021 Completed Generating Revenue
To view HighRAD’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HighRAD Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HighRAD Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
20/20 HealthCare Partners Family Office Minority
Hadasit Venture Capital Minority
Integra Holdings Venture Capital Minority
Yissum Accelerator/Incubator
To view HighRAD’s complete investors history, request access »

HighRAD FAQs

  • When was HighRAD founded?

    HighRAD was founded in 2019.

  • Where is HighRAD headquartered?

    HighRAD is headquartered in Tel Aviv, Israel.

  • What is the size of HighRAD?

    HighRAD has 7 total employees.

  • What industry is HighRAD in?

    HighRAD’s primary industry is Outcome Management (Healthcare).

  • Is HighRAD a private or public company?

    HighRAD is a Private company.

  • What is HighRAD’s current revenue?

    The current revenue for HighRAD is .

  • Who are HighRAD’s investors?

    20/20 HealthCare Partners, Hadasit, Integra Holdings, and Yissum have invested in HighRAD.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process